一项双盲随机安慰剂对照平行研究:探讨性别与膳食硝酸盐对健康男女COVID-19疫苗诱导血管功能障碍的影响——DiNOVasc-COVID-19研究方案
DiNOVasc-COVID-19是一项双盲、随机、单中心、安慰剂对照临床试验,计划招募98名健康志愿者(49男49女),随机进入A或B子研究。A子研究探讨性别对COVID-19疫苗血管与炎症反应的影响;B子研究探讨性别及膳食无机硝酸盐(含硝酸盐甜菜根汁 vs 去硝酸盐甜菜根汁,3天)的影响。两个子研究主要结局均为比较接种疫苗后血流介导舒张(FMD)相对基线的变化,把握度>80%。
要点
- DiNOVasc-COVID-19为双盲随机单中心安慰剂对照试验,计划招募98名健康志愿者(49男49女)。
- B子研究中参与者随机接受含硝酸盐或去硝酸盐甜菜根汁3天,比较疫苗后FMD变化。
- 两个子研究主要结局均为COVID-19疫苗接种后FMD相对基线的变化,把握度>80%。
核心结论
- 本研究旨在评估性别或膳食因素是否影响健康志愿者接种COVID-19疫苗后的内皮功能和炎症反应。
研究设计与样本
- DiNOVasc-COVID-19是一项双盲、随机、单中心、安慰剂对照临床试验,计划招募98名健康志愿者(49名男性和49名女性)。
- 参与者被随机分配到A子研究或B子研究;A子研究探讨性别对COVID-19疫苗血管和炎症反应的影响,B子研究探讨性别和膳食无机硝酸盐对COVID-19疫苗血管和炎症反应的影响。
- B子研究中,参与者被随机分配接受含硝酸盐甜菜根汁(干预)或去硝酸盐甜菜根汁(安慰剂)3天。
- 两个子研究的主要结局均为比较COVID-19疫苗接种后血流介导舒张(FMD)相对基线的变化,研究对主要终点的把握度>80%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiovascular events, driven by endothelial dysfunction, are a recognised complication of COVID-19. SARS-CoV-2 infections remain a persistent concern globally, and an understanding of the mechanisms causing endothelial dysfunction, particularly the role of inflammation, nitric oxide, and whether sex differences exist in this response, is lacking. We have previously demonstrated important sex differences in the inflammatory response and its impact on endothelial function and separately that the ingestion of inorganic nitrate can protect the endothelium against this dysfunction. In this study, we will investigate whether sex or a dietary inorganic nitrate intervention modulates endothelial function and inflammatory responses after the COVID-19 vaccine. METHODS: DiNOVasc-COVID-19 is a double-blind, randomised, single-centre, placebo-controlled clinical trial. A total of 98 healthy volunteers (49 males and 49 females) will be recruited. Participants will be randomised into 1 of 2 sub-studies: part A or part B. Part A will investigate the effects of sex on vascular and inflammatory responses to the COVID-19 vaccine. Part B will investigate the effects of sex and dietary inorganic nitrate on vascular and inflammatory responses to the COVID-19 vaccine. In part B, participants will be randomised to receive 3 days of either nitrate-containing beetroot juice (intervention) or nitrate-deplete beetroot juice (placebo). The primary outcome for both sub-studies is a comparison of the change in flow-mediated dilatation (FMD) from baseline after COVID-19 vaccination. The study has a power of > 80% to assess the primary endpoint. Secondary endpoints include change from baseline in inflammatory and leukocyte counts and in pulse wave analysis (PWA) and pulse wave velocity (PWV) following the COVID-19 vaccination. DISCUSSION: This study aims to evaluate whether sex or dietary influences endothelial function and inflammatory responses in healthy volunteers after receiving the COVID-19 vaccine. TRIAL REGISTRATION: ClinicalTrials.gov NCT04889274. Registered on 5 May 2023. The study was approved by the South Central - Oxford C Research Ethics Committee (21/SC/0154).
引用
- Shabbir A, Chhetri I, Khambata RS, et al. A double-blind, randomised, placebo-controlled parallel study to investigate the effect of sex and dietary nitrate on COVID-19 vaccine-induced vascular dysfunction in healthy men and women: protocol of the DiNOVasc-COVID-19 study. Trials. 2023. PMID: 37715222. doi:10.1186/s13063-023-07616-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。